1. Incidence and Impact of Thrombocytopenia in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents
- Author
-
Seung-Jung Park, Sang-Cheol Cho, Duk-Woo Park, Pil Hyung Lee, Hanbit Park, Jung-Min Ahn, Sangwoo Park, Tae Oh Kim, and Do-Yoon Kang
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Myocardial Infarction ,Comorbidity ,Coronary Artery Disease ,Postoperative Hemorrhage ,Severity of Illness Index ,Coronary artery disease ,Percutaneous Coronary Intervention ,Postoperative Complications ,Risk Factors ,Cause of Death ,Internal medicine ,Antithrombotic ,Severity of illness ,medicine ,Humans ,cardiovascular diseases ,Mortality ,Aged ,Proportional Hazards Models ,Cause of death ,Duration of Therapy ,business.industry ,Dual Anti-Platelet Therapy ,Incidence ,Incidence (epidemiology) ,Percutaneous coronary intervention ,Drug-Eluting Stents ,Middle Aged ,Prognosis ,medicine.disease ,Thrombocytopenia ,Surgery ,Stroke ,surgical procedures, operative ,Multivariate Analysis ,Conventional PCI ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Platelet Aggregation Inhibitors - Abstract
Platelets are crucial in the pathophysiology of coronary artery disease and are a major target of antithrombotic agents in patients receiving percutaneous coronary intervention (PCI). We sought to evaluate the incidence and prognostic impact of thrombocytopenia on clinical outcomes in patients undergoing PCI with drug-eluting stents (DES). We evaluated consecutive patients who received PCI with DES in the IRIS-DES registry between April 2008 and December 2017. Patients were divided into 2 groups based on the presence of thrombocytopenia (platelet count150 × 10
- Published
- 2020